Isoniazid Suppliers & Bulk Manufacturers
Available Forms: Tablet
Available Strengths: 100 mg, 300 mg
Reference Brands: Nydrazid®(US); Rimifon® (Germany)
Category:
Respiratory Disorder
Isoniazid is a key antitubercular drug used to treat and prevent pulmonary TB. It inhibits mycolic acid synthesis in Mycobacterium tuberculosis. Available as tablets (100 mg, 300 mg), oral liquid, and injectable, it's sold under brands like Nydrazid®, Rimifon®, Isokin®, and in fixed-dose combinations.
Isoniazid is available in Tablet
and strengths such as 100 mg, 300 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Isoniazid is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Isoniazid can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Isoniazid is a first-line antitubercular drug used for the treatment and prevention of tuberculosis (TB), especially pulmonary TB. It works by inhibiting mycolic acid synthesis, essential for the bacterial cell wall. Isoniazid is available in tablet form (100 mg, 300 mg), oral liquid (50 mg/5 mL), and injectable solution (100 mg/mL). Common brands include Nydrazid® (US), Rimifon® (EU), Isokin®, Isonex® (India). It is also included in fixed-dose combinations with Rifampicin and other TB drugs. Widely used in national TB programs, Isoniazid is essential in the global fight against tuberculosis and recommended by the WHO and CDC.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing